Results 41 to 50 of about 1,274,904 (321)

Prevention of infection and disruption of the pathogen transfer chain in elective surgery [PDF]

, 2020
The COVID-19 pandemic has caused us all to stop our normal activities and consider how we can safely return to caring for our patients. There are many common practices (such as an increased use of personal protective equipment) which we are all familiar ...
Chisari, Emanuele, Krueger, Chad A., Lowry Barnes, C., Parvizi, Javad, Van Onsem, Stefaan, Walter, William   +5 more
core   +2 more sources

A brief overview of current drug repurposing approaches for COVID-19 management [PDF]

, 2020
This brief overview is intended to shed light on the current drug repositioning (also called drug repurposing) in the therapeutics of the novel coronavirus disease which emerged in 2019 (COVID-19).
Rodrigues, Pedro da Fonseca Soares, Thomaz, Douglas Vieira   +1 more
core   +2 more sources

Maternal SARS‐CoV‐2 infection: The potential vertical transmission of SARS‐CoV‐2 and impact on neonates: A review

Pediatric Discovery, 2023
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a large, lipid‐enveloped, single‐stranded RNA virus, is a highly contagious virus that caused coronavirus disease 2019 (COVID‐19), declared a pandemic by the World Health Organization on March
Wei Xia, Zhoujie Peng
doaj   +1 more source

Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19. [PDF]

, 2020
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a novel beta-coronavirus that has recently emerged as the cause of the 2019 coronavirus pandemic (COVID-19).
Fitzgerald, Robert L, Hoffman, Melissa A, Kelner, Michael J, McLawhon, Ronald W, Reed, Sharon L, Suhandynata, Raymond T   +5 more
core  

Repurposing Interleukin-6 Inhibitors to Combat COVID-19. [PDF]

, 2020
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is a pandemic with major implications across the world. One of the most frequent causes of death from SARS-CoV-2 is fatal pneumonia from coronavirus disease 2019 (COVID-19), which is associated
Kato, Shumei, Kurzrock, Razelle
core   +1 more source

SARS-CoV-2 Entry Genes Are Most Highly Expressed in Nasal Goblet and Ciliated Cells within Human Airways [PDF]

Nature Medicine, 2020
We investigated SARS-CoV-2 potential tropism by surveying expression of viral entry-associated genes in single-cell RNA-sequencing data from multiple tissues from healthy human donors. We co-detected these transcripts in specific respiratory, corneal and
W. Sungnak, N. Huang, C. Bécavin, M. Berg, R. Queen, Monika Litviňuková, Carlos Talavera-López, H. Maatz, D. Reichart, F. Sampaziotis, Kaylee B. Worlock, Masahiro Yoshida, Josephine L. Barnes, Nicholas E. Pascal Alvis Joseph Tushar J. Thu Elizabeth Oli Banovich Barbry Brazma Collin Desai Duong Eickelbe, N. Banovich, P. Barbry, A. Brazma, J. Collin, T. Desai, T. Duong, O. Eickelberg, C. Falk, M. Farzan, I. Glass, Ravindra K. Gupta, M. Haniffa, P. Horváth, N. Hubner, Deborah T. Hung, N. Kaminski, M. Krasnow, J. Kropski, Malte Kuhnemund, M. Lako, Haeock Lee, S. Leroy, Sten Linnarson, J. Lundeberg, K. Meyer, Zhichao Miao, A. Misharin, M. Nawijn, M. Nikolić, M. Noseda, J. Ordovas-Montañes, G. Oudit, D. Pe’er, J. Powell, S. Quake, J. Rajagopal, P. R. Tata, E. Rawlins, A. Regev, P. Reyfman, O. Rozenblatt-Rosen, K. Saeb‐Parsy, C. Samakovlis, H. Schiller, J. Schultze, M. Seibold, C. Seidman, J. Seidman, A. Shalek, D. Shepherd, J. Spence, A. Spira, Xin Sun, S. Teichmann, Fabian J Theis, Alexander M. Tsankov, L. Vallier, M. van den Berge, J. Whitsett, R. Xavier, Yan Xu, L. Zaragosi, Darin Zerti, Hongbo Zhang, Kun Zhang, M. Rojas, Francisco Figueiredo   +80 more
semanticscholar   +1 more source

Therapeutic antibodies under development for SARS‐CoV‐2

View, 2022
The world is experiencing one of the most difficult moments in history with COVID‐19, which has rapidly developed into a worldwide pandemic with a significant health and economic burden.
Zetong Ma, MengMei Zhu, Shuyi Zhang, Kewen Qian, Chuqi Wang, Wenyan Fu, Changhai Lei, Shi Hu   +7 more
doaj   +1 more source

Pathophysiology, histopathology and therapeutic of SARS-CoV-2 [PDF]

, 2020
The rapid transmission of SARS-CoV-2 through the world has induced the scientist to understand the histopathology of the virus and then to find an effective drug.
Al-Gheethi, Adel, Al-Shorgani, Najeeb, Hezam, Kamal, Noman, Efaq, Othman, Norzila, Radin Mohamed, Radin Maya Saphira, Talip, Balkis   +6 more
core  

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

Science, 2020
Targeting a key enzyme in SARS-CoV-2 Scientists across the world are working to understand severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). Zhang et al.
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, U. Curth, C. Drosten, Lucie Sauerhering, S. Becker, K. Rox, R. Hilgenfeld   +8 more
semanticscholar   +1 more source

Guillain‐Barré syndrome after SARS‐CoV‐2 infection

Journal of General and Family Medicine, 2022
We herein report a case of Guillain‐Barré syndrome (GBS) after SARS‐CoV‐2 infection. The patient was a close contact with a SARS‐CoV‐2 patient. Initially, she did not have any symptoms and quarantined at a hotel.
Mikiya Kajita, Masamichi Sato, Yutaka Iizuka, Yamato Mashimo, Natsumi Furuta, Satoru Kakizaki   +5 more
doaj   +1 more source